137 related articles for article (PubMed ID: 36226777)
1. Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG.
Othus M; Thomas I; Wang X; Ariti C; Mehta P; Sydenham M; Hills RK; Burnett AK; Nand S; Assouline S; Michaelis LC; Erba HP; Russell N; Kerr KF; Walter RB; Dennis M
Leuk Lymphoma; 2023 Jan; 64(1):250-252. PubMed ID: 36226777
[No Abstract] [Full Text] [Related]
2. Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center.
Walter RB; Othus M; Burnett AK; Löwenberg B; Kantarjian HM; Ossenkoppele GJ; Hills RK; Ravandi F; Pabst T; Evans A; Pierce SR; Vekemans MC; Appelbaum FR; Estey EH
Leukemia; 2015 Feb; 29(2):312-20. PubMed ID: 25113226
[TBL] [Abstract][Full Text] [Related]
3. Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI.
Othus M; van Putten W; Lowenberg B; Petersdorf SH; Nand S; Erba H; Appelbaum F; Hills R; Russell N; Burnett A; Estey E
Haematologica; 2016 Jul; 101(7):e284-6. PubMed ID: 27013652
[No Abstract] [Full Text] [Related]
4. Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group.
Chanswangphuwana C; Polprasert C; Owattanapanich W; Kungwankiattichai S; Tantiworawit A; Rattanathammethee T; Limvorapitak W; Saengboon S; Niparuck P; Puavilai T; Julamanee J; Saelue P; Wanitpongpun C; Nakhakes C; Prayongratana K; Sriswasdi C
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):e1075-e1083. PubMed ID: 36117042
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients.
Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM
Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy.
Montalban-Bravo G; Kanagal-Shamanna R; Class CA; Sasaki K; Ravandi F; Cortes JE; Daver N; Takahashi K; Short NJ; DiNardo CD; Jabbour E; Borthakur G; Naqvi K; Issa GC; Konopleva M; Khoury JD; Routbort M; Pierce S; Do KA; Bueso-Ramos C; Patel K; Kantarjian H; Garcia-Manero G; Kadia TM
Am J Hematol; 2020 Jun; 95(6):612-622. PubMed ID: 32112433
[TBL] [Abstract][Full Text] [Related]
7. Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients.
Walter RB; Othus M; Burnett AK; Löwenberg B; Kantarjian HM; Ossenkoppele GJ; Hills RK; van Montfort KG; Ravandi F; Evans A; Pierce SR; Appelbaum FR; Estey EH
Blood; 2013 Mar; 121(13):2424-31. PubMed ID: 23325837
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC).
Arber DA; Erba HP
Am J Clin Pathol; 2020 Nov; 154(6):731-741. PubMed ID: 32864703
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of newly diagnosed acute myeloid leukemia with myelodysplasia related changes and elderly acute myeloid leukemia following decitabine therapy in combination with priming regimen.
Lai B; Mu Q; Zhang Y; Chen Y; Yan X; Ouyang G
Hematology; 2021 Dec; 26(1):751-757. PubMed ID: 34555298
[TBL] [Abstract][Full Text] [Related]
10. Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Harada K; Konuma T; Machida S; Mori J; Aoki J; Uchida N; Ohashi K; Fukuda T; Tanaka M; Ikegame K; Ozawa Y; Iwato K; Eto T; Onizuka M; Ichinohe T; Atsuta Y; Yano S
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1730-1743. PubMed ID: 31054982
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.
Ikegawa S; Doki N; Kurosawa S; Yamaguchi T; Sakaguchi M; Harada K; Yamamoto K; Hino Y; Shingai N; Senoo Y; Watanabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Leuk Lymphoma; 2016; 57(1):76-80. PubMed ID: 26084204
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated
Nguyen L; Zhang X; Roberts E; Yun S; McGraw K; Abraham I; Song J; Braswell D; Qin D; Sallman DA; Lancet JE; List AF; Moscinski LC; Padron E; Zhang L
Leuk Lymphoma; 2020 Jun; 61(6):1395-1405. PubMed ID: 32091281
[TBL] [Abstract][Full Text] [Related]
13. [Clinical importance of morphological multilineage dysplasia in acute myeloid leukemia with myelodysplasia related changes].
Park SH; Chi HS; Park SJ; Jang S; Park CJ
Korean J Lab Med; 2010 Jun; 30(3):231-8. PubMed ID: 20603581
[TBL] [Abstract][Full Text] [Related]
14. Distinct Mutation Landscapes Between Acute Myeloid Leukemia With Myelodysplasia-Related Changes and De Novo Acute Myeloid Leukemia.
Gao Y; Jia M; Mao Y; Cai H; Jiang X; Cao X; Zhou D; Li J
Am J Clin Pathol; 2022 May; 157(5):691-700. PubMed ID: 34664628
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
Mi YC; Xue YP; Yu WJ; Liu SH; Zhao YZ; Meng QX; Bian SG; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):705-9. PubMed ID: 16620570
[TBL] [Abstract][Full Text] [Related]
16. Karyotype plus NPM1 mutation status defines a group of elderly patients with AML (≥60 years) who benefit from intensive post-induction consolidation therapy.
Sperr WR; Zach O; Pöll I; Herndlhofer S; Knoebl P; Weltermann A; Streubel B; Jaeger U; Kundi M; Valent P
Am J Hematol; 2016 Dec; 91(12):1239-1245. PubMed ID: 27643573
[TBL] [Abstract][Full Text] [Related]
17. Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.
Bouvier A; Hamel JF; Delaunay J; Delabesse E; Dumas PY; Ledoux MP; Peterlin P; Luquet I; Roth Guepin G; Bulabois CE; Gallego Hernanz MP; Guillerm G; Guieze R; Hicheri Y; Simand C; Himberlin C; Hunault-Berger M; Bernard M; Jourdan E; Caillot D; Dorvaux V; Tavernier E; Daguindau E; Banos A; Ojeda-Uribe M; Gyan E; Alexis M; Marolleau JP; Turlure P; Bouscary D; Humbrecht C; Zerazhi H; Béné MC; Pigneux A; Carre M; Ifrah N; Blanchet O; Vey N; Récher C; Cornillet-Lefèbvre P;
Eur J Haematol; 2021 Jul; 107(1):111-121. PubMed ID: 33765335
[TBL] [Abstract][Full Text] [Related]
18. [Strategies to improve therapeutic efficacy in childhood acute myeloid leukemia].
Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):108-10. PubMed ID: 24568899
[TBL] [Abstract][Full Text] [Related]
19. Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.
Luo H; Qin Y; Reu F; Ye S; Dai Y; Huang J; Wang F; Zhang D; Pan L; Zhu H; Wu Y; Niu T; Xiao Z; Zheng Y; Liu T
J Hematol Oncol; 2016 Nov; 9(1):125. PubMed ID: 27855695
[TBL] [Abstract][Full Text] [Related]
20. [The clinical analysis of haploidentical stem cell transplantation in myelodysplastic syndrome-associated acute myeloid leukemia].
Fei Q; Huang XJ; Liu Y; Xu LP; Zhang XH; Liu KY; Chen H; Chen YY; Wang Y
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):546-551. PubMed ID: 30122012
[No Abstract] [Full Text] [Related]
[Next] [New Search]